Home - Products - Others - Other Targets - 7-Bromoquinazoline-2,4(1H,3H)-Dione

7-Bromoquinazoline-2,4(1H,3H)-Dione

CAS No. 114703-12-7

7-Bromoquinazoline-2,4(1H,3H)-Dione( 7-bromoquinazoline-2,4-diol | 7-Bromo-1H-quinazoline-2,4-dione )

Catalog No. M29556 CAS No. 114703-12-7

7-Bromoquinazoline-2,4(1H,3H)-Dione is a marine derived natural products found in Pyura sacciformis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 29 In Stock
25MG 51 In Stock
50MG 75 In Stock
100MG 112 In Stock
200MG 168 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-Bromoquinazoline-2,4(1H,3H)-Dione
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Bromoquinazoline-2,4(1H,3H)-Dione is a marine derived natural products found in Pyura sacciformis.
  • Description
    7-Bromoquinazoline-2,4(1H,3H)-Dione is a marine derived natural products found in Pyura sacciformis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    7-bromoquinazoline-2,4-diol | 7-Bromo-1H-quinazoline-2,4-dione
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    114703-12-7
  • Formula Weight
    241.04
  • Molecular Formula
    C8H5BrN2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1NC(=O)C2=CC=C(Br)C=C2N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Dideoxyadenosine

    2',3'-Dideoxyadenosine is an inhibitor of HIV replication, exhibiting antiretroviral activity and antiviral efficacy .

  • 6-Chloropurine

    6-Chloropurine is a building block in chemical synthesiswith?Antitumor activities.

  • Ethyl oleate

    Ethyl oleate is the liquid lipid component in nanostructured lipid carriers (NLCs).?NLC is a promising vehicle for oral trans-Ferulic acid (TFA) administration.?